Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dawn C. Bir was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Martin W. Edwards, M.D. resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
At the Effective Time, each of Martin W. Edwards, M.D., William D. McClellan, Jr. and R. Kent McGaughy Jr., resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Manmeet S. Soni was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
J. Warren Huff resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective as of immediately following the Effective Time, each of J. Warren Huff, Christy J. Oliger, William E. Rose, Shamim Ruff and Steven W. Ryder also resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andrea L. Loewen was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robin Kramer was appointed as Director at REATA PHARMACEUTICALS INC.
- Action
- became a director
- Role
- Director
Exact text from the filing
At the Effective Time, each of Fearghas Carruthers, Michael Dambach and Robin Kramer became a director of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Shamim Ruff resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective as of immediately following the Effective Time, each of J. Warren Huff, Christy J. Oliger, William E. Rose, Shamim Ruff and Steven W. Ryder also resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Seemi Khan, M.D. was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bhaskar Anand was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steven W. Ryder resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective as of immediately following the Effective Time, each of J. Warren Huff, Christy J. Oliger, William E. Rose, Shamim Ruff and Steven W. Ryder also resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
J. Warren Huff was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
R. Kent McGaughy Jr. resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
At the Effective Time, each of Martin W. Edwards, M.D., William D. McClellan, Jr. and R. Kent McGaughy Jr., resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rajiv Patni, M.D. was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William E. Rose resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective as of immediately following the Effective Time, each of J. Warren Huff, Christy J. Oliger, William E. Rose, Shamim Ruff and Steven W. Ryder also resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael D. Wortley was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Dambach was appointed as Director at REATA PHARMACEUTICALS INC.
- Action
- became a director
- Role
- Director
Exact text from the filing
At the Effective Time, each of Fearghas Carruthers, Michael Dambach and Robin Kramer became a director of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christy J. Oliger resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective as of immediately following the Effective Time, each of J. Warren Huff, Christy J. Oliger, William E. Rose, Shamim Ruff and Steven W. Ryder also resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Colin J. Meyer, M.D. was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William D. McClellan, Jr. resigned as Director at REATA PHARMACEUTICALS INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
At the Effective Time, each of Martin W. Edwards, M.D., William D. McClellan, Jr. and R. Kent McGaughy Jr., resigned as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Fearghas Carruthers was appointed as Director at REATA PHARMACEUTICALS INC.
- Action
- became a director
- Role
- Director
Exact text from the filing
At the Effective Time, each of Fearghas Carruthers, Michael Dambach and Robin Kramer became a director of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dakota Gallivan was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
W. Christian Wigley, Ph.D. was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steve Harman was removed as other_named_officer at REATA PHARMACEUTICALS INC.
- Action
- removed
Exact text from the filing
Additionally, effective as of immediately following the Effective Time, each of J. Warren Huff, Manmeet S. Soni, Dawn C. Bir, Colin J. Meyer, M.D., Rajiv Patni, M.D., Michael D. Wortley, Bhaskar Anand, Steve Harman, Seemi Khan, M.D., Andrea L. Loewen, W. Christian Wigley, Ph.D. and Dakota Gallivan was removed as an officer of Reata.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
REATA PHARMACEUTICALS INC: Amended and restated certificate of incorporation and bylaws effective upon merger.
- Change
- fiscal year change
Exact text from the filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information set forth in the section above titled “Introduction” of this Current Report on Form 8-K is incorporated herein by reference. Copies of the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws, the Second Amended and Restated Certificate of Incorporation and the Second Amended and Restated Bylaws are filed as Exhibits 3.1, 3.2, 3.3 and 3.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
REATA PHARMACEUTICALS INC underwent a change of control involving Biogen Inc. for $172.50 in cash (closed 2023-09-26).
- Action
- change of control
- Counterparty
- Biogen Inc.
- Consideration
- $172.50 in cash
- Closing
- 2023-09-26
Exact text from the filing
the Reata Common Stock with respect to which statutory rights of appraisal were properly and validly demanded) was automatically canceled and converted into the right to receive $172.50 in cash, without interest and subject to any applicable withholding taxes (the “ Merger Consideration ”). In addition, effective as of immediately prior to the Effective Time, (i)
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.